Institut biostatistiky a analyz s.r.o
Institut biostatistiky a analyz s.r.o is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
Phase 2 study of belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Sponsor Ceska Myelomova Skupina z.s.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Institut biostatistiky a analyz s.r.o?
The 2026-10-09 snapshot links Institut biostatistiky a analyz s.r.o to 1 distinct CTIS trials. Recorded services include Data management, Safety reporting & pharmacovigilance, Statistical analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Institut biostatistiky a analyz s.r.o?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Institut biostatistiky a analyz s.r.o conducted?
The linked trials record locations in 1 country, including Czechia. These are trial locations, not confirmed office locations or countries where Institut biostatistiky a analyz s.r.o delivered services.
What can this page tell me about Institut biostatistiky a analyz s.r.o's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Institut biostatistiky a analyz s.r.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Institut biostatistiky a analyz s.r.o.